医学
肌腱病
肌腱
白细胞介素17
离体
封锁
炎症
肩袖
免疫学
体内
内科学
病理
外科
生物
受体
生物技术
作者
Neal L. Millar,Iain B. McInnes,Frank Kolbinger,Friedrich Raulf,Moeed Akbar,Yufei Li,Nicolau Beckmann,Nathalie Accart,Olivier Leupin,Claudio Calonder,Matthias Schieker,Michaela Kneissel,Christian Bruns,Richard M. Siegel,Eckhard Weber
出处
期刊:RMD Open
[BMJ]
日期:2025-01-01
卷期号:11 (1): e004729-e004729
被引量:2
标识
DOI:10.1136/rmdopen-2024-004729
摘要
Objectives Tendinopathy is a frequent clinical problem and represents an extraordinary health economic and socioeconomic burden with high unmet medical needs. Recent clinical evidence suggests blockade of interleukin 17A (IL-17A) for tendinopathy therapy. The present preclinical study elucidates the biological mechanisms of IL-17A pathway stimulation and blockade in tendinopathy. Methods We explored whether IL-17A and other IL-17 family members are differentially expressed in biopsies of healthy, early-stage and late-stage tendinopathic human rotator cuff tendons using RT-qPCR. IL-17 pathway signature genes in healthy human tendon-derived cells were identified following IL-17A stimulation using AmpliSeq RNA. The molecular, structural and functional consequences of IL-17A pathway stimulation were explored in healthy human tendon-derived cells and in a rat tendon fascicle model ex vivo. The effects of IL-17A pathway blockade were investigated in a rat model of rotator cuff tendinopathy in vivo. Results We provide evidence of differential expression of IL-17A mRNA ( IL17A ) versus other IL-17 family members in human rotator cuff early-stage tendinopathy. In human tendon-derived cells, stimulation with IL-17A induced the expression of the selected IL-17A pathway signature genes NFKBIZ, ZC3H12A, CXCL1, IL6, MMP3 . Expression was inhibited by IL-17A blockade. In the rat ex vivo and in vivo models, IL-17A blockade alleviated inflammatory immune effector release, tendon structural degeneration, tendon inflammation and impaired tendon function. Conclusion Our data provide evidence that IL-17A is a key contributor to the pathogenesis of tendinopathy by promoting tendon inflammation and degeneration and that IL-17A blockade may represent a potential therapy in early-stage tendinopathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI